AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34
Tamoxifen and breast cancer risk in women harboring a BRCA1 germline mutation: computed efficacy, effectiveness and impact
Authors: Eisinger, F Charafe-Jauffret, E Jacquemier, J Birnbaum, D Julian-Reynier, C Sobol, H
Citation: F. Eisinger et al., Tamoxifen and breast cancer risk in women harboring a BRCA1 germline mutation: computed efficacy, effectiveness and impact, INT J ONCOL, 18(1), 2001, pp. 5-10
WNT pathway and mammary carcinogenesis: Loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type
Authors: Ugolini, F Charafe-Jauffret, E Bardou, VJ Geneix, J Adelaide, J Labat-Moleur, F Penault-Llorca, F Longy, M Jacquemier, J Birnbaum, D Pebusque, MJ
Citation: F. Ugolini et al., WNT pathway and mammary carcinogenesis: Loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type, ONCOGENE, 20(41), 2001, pp. 5810-5817
Prognostic factors in localized primary synovial sarcoma: A multicenter study of 128 adult patients
Authors: Trassard, M Le Doussal, V Hacene, K Terrier, P Ranchere, D Guillou, L Fiche, M Collin, F Vilain, MO Bertrand, G Jacquemier, J Sastre-Garau, X Bui, NB Bonichon, F Coindre, JM
Citation: M. Trassard et al., Prognostic factors in localized primary synovial sarcoma: A multicenter study of 128 adult patients, J CL ONCOL, 19(2), 2001, pp. 525-534
Assessing the risk of BRCA1-associated breast cancer using individual morphological criteria
Authors: Jacquemier, J Lidereau, R Birnbaum, D Eisinger, F Sobol, H
Citation: J. Jacquemier et al., Assessing the risk of BRCA1-associated breast cancer using individual morphological criteria, HISTOPATHOL, 38(4), 2001, pp. 378-379
PS2-expression in BRCA1-associated breast cancers
Authors: Charafe-Jauffret, E Eisinger, F Mathoulin-Portier, MP Hassoun, J Birnbaum, D Sobol, H Jacquemier, J
Citation: E. Charafe-jauffret et al., PS2-expression in BRCA1-associated breast cancers, ANTICANC R, 21(4B), 2001, pp. 2877-2881
Mammary carcinoma arising in microglandular adenosis: a case report
Authors: Charafe-Jauffret, E Jacquemier, J Lelong, B Meynard, P Mathoulin-Portier, MP Houvenhaegel, G Hassoun, J
Citation: E. Charafe-jauffret et al., Mammary carcinoma arising in microglandular adenosis: a case report, ANN PATHOL, 21(5), 2001, pp. 435-438
Molecular typing of breast cancer: transcriptomics and DNA microarrays
Authors: Bertucci, F Houlgatte, R Nguyen, C Benziane, A Nasser, V Granjeaud, S Tagett, B Loriod, B Giaconia, A Jacquemier, J Viens, P Birnbaum, D
Citation: F. Bertucci et al., Molecular typing of breast cancer: transcriptomics and DNA microarrays, B CANCER, 88(3), 2001, pp. 277-286
The pathology of familial breast cancer: Histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2
Authors: Lakhani, SR Gusterson, BA Jacquemier, J Sloane, JP Anderson, TJ van de Vijver, MJ Venter, D Freeman, A Antoniou, A McGuffog, L Smyth, E Steel, CM Haites, N Scott, RJ Goldgar, D Neuhausen, S Daly, PA Ormiston, W McManus, R Scherneck, S Ponder, BAJ Futreal, PA Peto, J Stoppa-Lyonnet, D Bignon, YJ Struewing, JP Bishop, DT Klijn, JGM Devilee, P Cornelisse, CJ Lasset, C Lenoir, G Barkardottir, RB Egilsson, V Hamann, U Chang-Claude, J Sobol, H Weber, B Easton, DF Stratton, MR
Citation: Sr. Lakhani et al., The pathology of familial breast cancer: Histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2, CLIN CANC R, 6(3), 2000, pp. 782-789
Prognostic value of simultaneous expression of p21 and mdm2 in breast carcinomas treated by adjuvant chemotherapy with antracyclin
Authors: Mathoulin-Portier, MP Viens, P Cowen, D Bertucci, F Houvenaeghel, G Geneix, J Puig, B Bardou, VJ Jacquemier, J
Citation: Mp. Mathoulin-portier et al., Prognostic value of simultaneous expression of p21 and mdm2 in breast carcinomas treated by adjuvant chemotherapy with antracyclin, ONCOL REP, 7(3), 2000, pp. 675-680
Translocation and coamplification of loci from chromosome arms 8p and 11q in the MDA-MB-175 mammary carcinoma cell line
Authors: Adelaide, J Chaffanet, M Mozziconacci, MJ Popovici, C Conte, N Fernandez, F Sobol, H Jacquemier, J Pebusque, MJ Ron, D Lafage-Pochitaloff, M Birnbaum, D
Citation: J. Adelaide et al., Translocation and coamplification of loci from chromosome arms 8p and 11q in the MDA-MB-175 mammary carcinoma cell line, INT J ONCOL, 16(4), 2000, pp. 683-688
Gene expression profiling of primary breast carcinomas using arrays of candidate genes
Authors: Bertucci, F Houlgatte, R Benziane, A Granjeaud, S Adelaide, J Tagett, R Loriod, B Jacquemier, J Viens, P Jordan, B Birnbaum, D Nguyen, C
Citation: F. Bertucci et al., Gene expression profiling of primary breast carcinomas using arrays of candidate genes, HUM MOL GEN, 9(20), 2000, pp. 2981-2991
Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast
Authors: Elston, CW Sloane, JP Amendoeira, I Apostolikas, N Bellocq, JP Bianchi, S Boecker, W Bussolati, G Coleman, D Connolly, CE Dervan, P Drijkoningen, M Eusebi, V Faverly, D Holland, R Jacquemier, J Lacerda, M Martinez-Penuela, J de Miguel, C Moss, S Munt, C Peterse, JL Rank, F Reiner, A Sylvan, M Wells, CA Zafrani, B
Citation: Cw. Elston et al., Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast, EUR J CANC, 36(14), 2000, pp. 1769-1772
Local and distant failures after limited surgery with positive margins andradiotherapy for node-negative breast cancer
Authors: Cowen, D Houvenaeghel, G Bardou, VJ Jacquemier, J Bautrant, E Conte, M Viens, P Largillier, R Puig, B Resbeut, M Maraninchi, D
Citation: D. Cowen et al., Local and distant failures after limited surgery with positive margins andradiotherapy for node-negative breast cancer, INT J RAD O, 47(2), 2000, pp. 305-312
Outpatient sequential high dose alkylation with stem cell support for patients with advanced breast cancer: A phase I-II study
Authors: Genre, D Viens, P Gravis, G Bertucci, F Cowen, D Novakovitch, G Dermeche, S Chabannon, C Oziel-Taieb, S Camerlo, J Houvenaeghel, G Jacquemier, J Maraninchi, D
Citation: D. Genre et al., Outpatient sequential high dose alkylation with stem cell support for patients with advanced breast cancer: A phase I-II study, ANTICANC R, 20(3B), 2000, pp. 2033-2040
Fallopian tube cancer as a feature of BRCA1-associated syndromes
Authors: Sobol, H Jacquemier, J Bonaiti, C Dauplat, J Birnbaum, D Eisinger, F
Citation: H. Sobol et al., Fallopian tube cancer as a feature of BRCA1-associated syndromes, GYNECOL ONC, 78(2), 2000, pp. 263-264
Prognosis of breast-carcinoma lymphagenesis evaluated by immunohistochemical investigation of vascular-endothelial-growth-factor receptor 3
Authors: Jacquemier, J Mathoulin-Portier, MP Valtola, R Charafe-Jauffret, E Geneix, J Houvenaeghel, G Puig, B Bardou, VJ Hassoun, J Viens, P Birnbaum, D
Citation: J. Jacquemier et al., Prognosis of breast-carcinoma lymphagenesis evaluated by immunohistochemical investigation of vascular-endothelial-growth-factor receptor 3, INT J CANC, 89(1), 2000, pp. 69-73
VEGFc and VEGFR3 expression in human thyroid pathologies
Authors: Shushanov, S Bronstein, M Adelaide, J Jussila, L Tchipysheva, T Jacquemier, J Stavrovskaya, A Birnbaum, D Karamysheva, A
Citation: S. Shushanov et al., VEGFc and VEGFR3 expression in human thyroid pathologies, INT J CANC, 86(1), 2000, pp. 47-52
Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer
Authors: Lidereau, R Eisinger, F Champeme, MH Nogues, C Bieche, I Birnbaum, D Pallud, C Jacquemier, J Sobol, H
Citation: R. Lidereau et al., Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer, CANCER RES, 60(5), 2000, pp. 1206-1210
More about: Multifactorial analysis of differences between sporadic breastcancers and cancers involving BRCA1 and BRCA2 mutations
Authors: Eisinger, F Jacquemier, J Charafe-Jauffret, E Rio, MC Birnbaum, D Sobol, H
Citation: F. Eisinger et al., More about: Multifactorial analysis of differences between sporadic breastcancers and cancers involving BRCA1 and BRCA2 mutations, J NAT CANC, 91(16), 1999, pp. 1421-1422
Hormone replacement therapy and screening mammography: analysis of the results in the Bouches du Rhone programme
Authors: Seradour, B Esteve, J Heid, P Jacquemier, J
Citation: B. Seradour et al., Hormone replacement therapy and screening mammography: analysis of the results in the Bouches du Rhone programme, J MED SCREE, 6(2), 1999, pp. 99-102
Differential expression assay of chromosome arm 8p genes identifies Frizzled-related (FRP1/FRZB) and Fibroblast Growth Factor Receptor 1 (FGFR1) as candidate breast cancer genes
Authors: Ugolini, F Adelaide, J Charafe-Jauffret, E Nguyen, C Jacquemier, J Jordan, B Birnbaum, D Pebusque, MJ
Citation: F. Ugolini et al., Differential expression assay of chromosome arm 8p genes identifies Frizzled-related (FRP1/FRZB) and Fibroblast Growth Factor Receptor 1 (FGFR1) as candidate breast cancer genes, ONCOGENE, 18(10), 1999, pp. 1903-1910
Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas
Authors: Sloane, JP Amendoeira, I Apostolikas, N Bellocq, JP Bianchi, S Boecker, W Bussolati, G Coleman, D Connolly, CE Eusebi, V De Miguel, C Dervan, P Drijkoningen, R Elston, CW Faverly, D Gad, A Jacquemier, J Lacerda, M Martinez-Penuela, J Munt, C Peterse, JL Rank, F Sylvan, M Tsakraklides, V Zafrani, B
Citation: Jp. Sloane et al., Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas, VIRCHOWS AR, 434(1), 1999, pp. 3-10
High-dose chemotherapy with hematopoietic stem cell support in patients with advanced epithelial ovarian cancer: Analysis of 67 patients treated in asingle institution
Authors: Bertucci, F Viens, P Gravis, G Blaise, D Faucher, C Oziel-Taoeb, S Bardou, VJ Jacquemier, J Delpero, JR Maraninchi, D
Citation: F. Bertucci et al., High-dose chemotherapy with hematopoietic stem cell support in patients with advanced epithelial ovarian cancer: Analysis of 67 patients treated in asingle institution, ANTICANC R, 19(2B), 1999, pp. 1455-1461
Peritumoral vascular invasion in women with node-negative breast cancer, receiving no adjuvant therapy
Authors: Mathoulin-Portier, MP Meynard, P Charton-Bain, MC Escoute, M Bardou, VJ Puig, B Viens, P Cowen, D Houvenaeghel, G Hassoun, J Jacquemier, J
Citation: Mp. Mathoulin-portier et al., Peritumoral vascular invasion in women with node-negative breast cancer, receiving no adjuvant therapy, ANTICANC R, 19(1B), 1999, pp. 843-847
Qualify challenge for immunohistochemistry: example of the ERBB-2 status in breast cancer
Authors: Penault-Llorca, F Jacquemier, J Le Doussal, V Voigt, JJ
Citation: F. Penault-llorca et al., Qualify challenge for immunohistochemistry: example of the ERBB-2 status in breast cancer, ANN PATHOL, 19(4), 1999, pp. 280-282
Risultati: 1-25 | 26-34